Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Kaori Mukai
Principal Scientist at Sanofi, USA
Speaker

Profile

Kaori Mukai is a Principal Scientist in Immune Checkpoint Cluster, Immunology & Inflammation Research at Sanofi in Cambridge, USA. She holds a PhD in Immunology from Tokyo Medical and Dental University in Japan. After her postdoc research at Stanford University in USA, she joined Sanofi. At Sanofi she has led multiple new drug development projects for inflammatory diseases.

Agenda Sessions

  • Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan

    14:00